Search Results - "Stet, E H"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts by Bökkerink, J P, Stet, E H, De Abreu, R A, Damen, F J, Hulscher, T W, Bakker, M A, van Baal, J A

    Published in Biochemical pharmacology (06-04-1993)
    “…The effects of prolonged exposure to 2 and 10 microM 6-mercaptopurine (6MP) in the human lymphoblastic T-cell line MOLT-4 were studied with respect to…”
    Get more information
    Journal Article
  2. 2

    The importance of methylthio-IMP for methylmercaptopurine ribonucleoside (Me-MPR) cytotoxicity in Molt F4 human malignant T-lymphoblasts by Vogt, M H, Stet, E H, De Abreu, R A, Bökkerink, J P, Lambooy, L H, Trijbels, F J

    Published in Biochimica et biophysica acta (30-04-1993)
    “…The importance of methyl-thioIMP (Me-tIMP) formation for methylmercaptopurine ribonucleoside (Me-MPR) cytotoxicity was studied in Molt F4 cells. Cytotoxicity…”
    Get more information
    Journal Article
  3. 3

    Decrease in S-adenosylmethionine synthesis by 6-mercaptopurine and methylmercaptopurine ribonucleoside in Molt F4 human malignant lymphoblasts by Stet, E H, De Abreu, R A, Bökkerink, J P, Blom, H J, Lambooy, L H, Vogels-Mentink, T M, de Graaf-Hess, A C, van Raay-Selten, B, Trijbels, F J

    Published in Biochemical journal (15-11-1994)
    “…6-Mercaptopurine (6-MP) and methylmercaptopurine ribonucleoside (Me-MPR) are purine anti-metabolites which are both metabolized to methylthio-IMP (Me-tIMP), a…”
    Get full text
    Journal Article
  4. 4

    A biochemical basis for synergism of 6-mercaptopurine and mycophenolic acid in Molt F4, a human malignant T-lymphoblastic cell line by Stet, E H, De Abreu, R A, Janssen, Y P, Bökkerink, J P, Trijbels, F J

    Published in Biochimica et biophysica acta (22-01-1993)
    “…6-Mercaptopurine (6MP) cytotoxicity was studied in Molt F4 cells, a T-cell acute lymphoblastic leukemia (ALL) cell line. The effects on cytotoxicity were…”
    Get more information
    Journal Article
  5. 5
  6. 6

    Reversal of methylmercaptopurine ribonucleoside cytotoxicity by purine ribonucleosides and adenine by Stet, Elisabet H., De Abreu, Ronney A., Bökkerink, Jos P.M., Lambooy, Lambert H.J., Vogels-Mentink, Trude M., Keizer-Garritsen, Jenneke J., Trijbels, Frans J.M.

    Published in Biochemical pharmacology (06-01-1995)
    “…6-Methylmercaptopurine ribonucleoside-5′-phosphate (MeSPuRMP), the sole metabolite of 6-methylmercaptopurine ribonucleoside (MeSPuRib), is a strong inhibitor…”
    Get full text
    Journal Article
  7. 7

    Reversal of 6-mercaptopurine and 6-methylmercaptopurine ribonucleoside cytotoxicity by amidoimidazole carboxamide ribonucleoside in Molt F4 human malignant T-lymphoblasts by Stet, E H, De Abreu, R A, Bökkerink, J P, Vogels-Mentink, T M, Lambooy, L H, Trijbels, F J, Trueworthy, R C

    Published in Biochemical pharmacology (03-08-1993)
    “…Cytotoxicity of 6-mercaptopurine (6MP) and 6-methylmercaptopurine ribonucleoside (Me-MPR) was studied in Molt F4 human malignant lymphoblasts. Both drugs are…”
    Get more information
    Journal Article
  8. 8

    Cell-kinetics and biochemical pharmacology of methotrexate and 6-mercaptopurine in human malignant T-lymphoblasts by Bökkerink, J P, De Abreu, R A, Stet, E H, Damen, F J

    Published in Klinische Pädiatrie (01-07-1992)
    “…The cell-kinetics and biochemical pharmacology of simultaneous and sequential combination treatment with 0.02 microM methotrexate (MTX) and 2 microM…”
    Get more information
    Journal Article
  9. 9

    Inhibition of IMP dehydrogenase by mycophenolic acid in Molt F4 human malignant lymphoblasts by Stet, E H, De Abreu, R A, Bökkerink, J P, Lambooy, L H, Vogels-Mentink, T M, Keizer-Garritsen, J J, Trijbels, F J

    Published in Annals of clinical biochemistry (01-03-1994)
    “…The effects of inhibition of inosine monophosphate dehydrogenase (IMPDH), the rate-limiting enzyme in guanine nucleotide de novo synthesis, on cell growth,…”
    Get more information
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13